|
1
|
Gordon IO, Sitterding S, Mackinnon AC and
Husain AN: Update in neoplastic lung diseases and mesothelioma.
Arch Pathol Lab Med. 133:1106–1115. 2009.PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
3
|
Mehran RJ: Lung cancer: an update on
current surgical strategies. Tex Heart Inst J. 39:844–845.
2012.PubMed/NCBI
|
|
4
|
Mao JT, Cui X, Reckamp K, et al:
Chemoprevention strategies with cyclooxygenase-2 inhibitors for
lung cancer. Clin Lung Cancer. 7:30–39. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dohadwala M, Batra RK, Luo J, et al:
Autocrine/paracrine prostaglandin E2 production by non-small cell
lung cancer cells regulates matrix metalloproteinase-2 and CD44 in
cyclooxygenase-2-dependent invasion. J Biol Chem. 277:50828–50833.
2002. View Article : Google Scholar
|
|
6
|
Krysan K, Reckamp KL, Dalwadi H, et al:
Prostaglandin E2 activates mitogen-activated protein kinase/Erk
pathway signaling and cell proliferation in non-small cell lung
cancer cells in an epidermal growth factor receptor-independent
manner. Cancer Res. 65:6275–6281. 2005. View Article : Google Scholar
|
|
7
|
Oshima H and Oshima M: The role of
PGE2-associated inflammatory responses in gastric cancer
development. Semin Immunopathol. 35:139–150. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Zhang Y, Kim WJ and Daaka Y: PGE2
promotes renal carcinoma cell invasion through activated RaIA.
Oncogene. 32:1408–1415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karavitis J, Hix LM, Shi YH, Schultz RF,
Khazaie K and Zhang M: Regulation of COX2 expression in mouse
mammary tumor cells controls bone metastasis and PGE2-induction of
regulatory T cell migration. PLoS One. 7:e463422012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hazra S and Dubinett SM: Ciglitazone
mediates COX-2 dependent suppression of PGE2 in human non-small
cell lung cancer cells. Prostaglandins Leukot Essent Fatty Acids.
77:51–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ho MY, Liang SM, Hung SW and Liang CM:
MIG-7 controls COX-2/PGE2-mediated lung cancer metastasis. Cancer
Res. 73:439–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boie Y, Stocco R, Sawyer N, et al:
Molecular cloning and characterization of the four rat
prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol.
340:227–241. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu H, Yang Y, Xiao J, et al:
COX-2-mediated regulation of VEGF-C in association with
lymphangiogenesis and lymph node metastasis in lung cancer. Anat
Rec (Hoboken). 293:1838–1846. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su JL, Shih JY, Yen ML, et al:
Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular
endothelial growth factor-C up-regulation: a novel mechanism of
lymphangiogenesis in lung adenocarcinoma. Cancer Res. 64:554–564.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schuppan D and Ocker M: Integrin-mediated
control of cell growth. Hepatology. 38:289–291. 2003. View Article : Google Scholar
|
|
16
|
Yao ES, Zhang H, Chen YY, et al: Increased
beta1 integrin is associated with decreased survival in invasive
breast cancer. Cancer Res. 67:659–664. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nikkola J, Vihinen P, Vlaykova T,
Hahka-Kemppinen M, Heino J and Pyrhönen S: Integrin chains beta1
and alphav as prognostic factors in human metastatic melanoma.
Melanoma Res. 14:29–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Müller-Klingspor V, Hefler L, Obermair A,
et al: Prognostic value of beta1-integrin (=CD29) in serous
adenocarcinomas of the ovary. Anticancer Res. 21:2185–2188.
2001.
|
|
19
|
Seales EC, Jurado GA, Brunson BA,
Wakefield JK, Frost AR and Bellis SL: Hypersialylation of beta1
integrins, observed in colon adenocarcinoma, may contribute to
cancer progression by up-regulating cell motility. Cancer Res.
65:4645–4652. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fong YC, Hsu SF, Wu CL, et al:
Transforming growth factor-beta1 increases cell migration and beta1
integrin up-regulation in human lung cancer cells. Lung Cancer.
64:13–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morello V, Cabodi S, Sigismund S, et al:
beta1 integrin controls EGFR signaling and tumorigenic properties
of lung cancer cells. Oncogene. 30:4087–4096. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang PF, Zeng GQ, Yi LZ, et al:
Identification of integrin β1 as a prognostic biomarker for human
lung adenocarcinoma using 2D-LCMS/MS combined with iTRAQ
technology. Oncol Rep. 30:341–349. 2013.
|
|
23
|
Han S, Sidell N, Roser-Page S and Roman J:
Fibronectin stimulates human lung carcinoma cell growth by inducing
cyclooxygenase-2 (COX-2) expression. Int J Cancer. 111:322–331.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pierro E, Minici F, Alesiani O, et al: In
vitro regulation of beta1 and beta3 integrin subunits in
endometrial epithelial cells from normal endometrium. Am J Reprod
Immunol. 49:373–376. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mayoral R, Fernández-Martínez A, Boscá L
and Martín-Sanz P: Prostaglandin E2 promotes migration and adhesion
in hepatocellular carcinoma cells. Carcinogenesis. 26:753–761.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu JF, Fong YC, Chang CS, et al:
Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell
migration via EP1 dependent signaling pathway in human
chondrosarcoma cells. Mol Cancer. 9:432010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun Q, Yao X, Ning Y, Zhang W, Zhou G and
Dong Y: Overexpression of response gene to complement 32 (RGC32)
promotes cell invasion and induces epithelial-mesenchymal
transition in lung cancer cells via the NF-κB signaling pathway.
Tumour Biol. 34:2995–3002. 2013.PubMed/NCBI
|
|
28
|
Falcone D, Gallelli L, Di Virgilio A, et
al: Effects of simvastatin and rosuvastatin on RAS protein, matrix
metalloproteinases and NF-κB in lung cancer and in normal pulmonary
tissues. Cell Prolif. 46:172–182. 2013.PubMed/NCBI
|
|
29
|
Abrahao AC, Castilho RM, Squarize CH,
Molinolo AA, dos Santos-Pinto D Jr and Gutkind JS: A role for
COX2-derived PGE2 and PGE2-receptor subtypes in head and neck
squamous carcinoma cell proliferation. Oral Oncol. 46:880–887.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leng J, Han C, Demetris AJ, Michalopoulos
GK and Wu T: Cyclooxygenase-2 promotes hepatocellular carcinoma
cell growth through Akt activation: evidence for Akt inhibition in
celecoxib-induced apoptosis. Hepatology. 38:756–768. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hussain T, Gupta S and Mukhtar H:
Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett.
191:125–135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao QT, Yue SQ, Cui Z, et al: Potential
involvement of the cyclooxygenase-2 pathway in hepatocellular
carcinoma-associated angiogenesis. Life Sci. 80:484–492. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bai XM, Zhang W, Liu NB, et al: Focal
adhesion kinase: important to prostaglandin E2-mediated adhesion,
migration and invasion in hepatocellular carcinoma cells. Oncol
Rep. 21:129–136. 2009.PubMed/NCBI
|
|
34
|
Han C and Wu T: Cyclooxygenase-2-derived
prostaglandin E2 promotes human cholangiocarcinoma cell growth and
invasion through EP1 receptor-mediated activation of the epidermal
growth factor receptor and Akt. J Biol Chem. 280:24053–24063. 2005.
View Article : Google Scholar
|
|
35
|
Buchanan FG, Wang D, Bargiacchi F and
DuBois RN: Prostaglandin E2 regulates cell migration via the
intracellular activation of the epidermal growth factor receptor. J
Biol Chem. 278:35451–35457. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun B, Rong R, Jiang H, et al:
Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2
expression in human cholangiocarcinoma cells. Mol Cell Biochem.
378:195–203. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bai XM, Jiang H, Ding JX, et al:
Prostaglandin E2 upregulates survivin expression via the EP1
receptor in hepatocellular carcinoma cells. Life Sci. 86:214–223.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang L, Jiang L, Sun Q, et al:
Prostaglandin E2 enhances mitogen-activated protein kinase/Erk
pathway in human cholangiocarcinoma cells: involvement of EP1
receptor, calcium and EGF receptors signaling. Mol Cell Biochem.
305:19–26. 2007. View Article : Google Scholar
|
|
39
|
Cary LA and Guan JL: Focal adhesion kinase
in integrin-mediated signaling. Front Biosci. 4:D102–D113. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Missan DS and DiPersio M: Integrin control
of tumor invasion. Crit Rev Eukaryot Gene Expr. 22:309–324. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang H, Ozaki I, Mizuta T, et al: Beta
1-integrin protects hepatoma cells from chemotherapy induced
apoptosis via a mitogen-activated protein kinase dependent pathway.
Cancer. 95:896–906. 2002. View Article : Google Scholar
|
|
42
|
Sethi T, Rintoul RC, Moore SM, et al:
Extracellular matrix proteins protect small cell lung cancer cells
against apoptosis: a mechanism for small cell lung cancer growth
and drug resistance in vivo. Nat Med. 5:662–668. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ju L and Zhou C: Association of integrin
beta1 and c-MET in mediating EGFR TKI gefitinib resistance in
non-small cell lung cancer. Cancer Cell Int. 13:152013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ju L, Zhou C, Li W and Yan L: Integrin
beta1 over-expression associates with resistance to tyrosine kinase
inhibitor gefitinib in non-small cell lung cancer. J Cell Biochem.
111:1565–1574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yazawa K, Tsuno NH, Kitayama J, et al:
Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell
adhesion to extracellular matrix by decreased expression of beta1
integrin. Cancer Sci. 96:93–99. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bai X, Wang J, Zhang L, et al:
Prostaglandin E2 receptor EP1-mediated phosphorylation
of focal adhesion kinase enhances cell adhesion and migration in
hepatocellular carcinoma cells. Int J Oncol. 42:1833–1841.
2013.
|
|
47
|
Tang CH, Yang RS and Fu WM: Prostaglandin
E2 stimulates fibronectin expression through EP1 receptor,
phospholipase C, protein kinase Calpha, and c-Src pathway in
primary cultured rat osteoblasts. J Biol Chem. 280:22907–22916.
2005. View Article : Google Scholar
|
|
48
|
Chen F, Beezhold K and Castranova V: Tumor
promoting or tumor suppressing of NF-kappa B, a matter of cell
context dependency. Int Rev Immunol. 27:183–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sen R and Smale ST: Selectivity of the
NF-{kappa}B response. Cold Spring Harb Perspect Biol.
2:a0002572010.
|
|
50
|
Okamoto T, Sanda T and Asamitsu K:
NF-kappa B signaling and carcinogenesis. Curr Pharm Des.
13:447–462. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ji R, Sanchez CM, Chou CL, Chen XB,
Woodward DF and Regan JW: Prostanoid EP1 receptors
mediate up-regulation of the orphan nuclear receptor
Nurr1 by cAMP-independent activation of protein kinase
A, CREB and NF-κB. Br J Pharmacol. 166:1033–1046. 2012.PubMed/NCBI
|
|
52
|
Melisi D and Chiao PJ: NF-kappa B as a
target for cancer therapy. Expert Opin Ther Targets. 11:133–144.
2007. View Article : Google Scholar : PubMed/NCBI
|
